Laboratory experiments increase new product development cost. Special experiments for predictive model calibration reduces benefits of models.
Use Glycosylation modeling to reduce laboratory experimentation. Calibrate predictive model using AI/ML rather than experiments.
Reduce process development time and cost of Antibody products
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
Massachusetts Institute of Technology
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Cytiva
Federal Stakeholder: National Institute of Standards and Technology
Genentech, Inc.
Merck Sharp & Dohme LLC
MilliporeSigma/EMD Serono
NIIMBL
Pfizer, Inc.
Sanofi